149 related articles for article (PubMed ID: 32933950)
1. Comparison of weight-based insulin titration (WIT) and glucose-based insulin titration using basal-bolus algorithm in hospitalized patients with type 2 diabetes: a multicenter, randomized, clinical study.
Zhang X; Zhang T; Xiang G; Wang W; Li Y; Du T; Zhao Y; Mosha SS; Li W
BMJ Open Diabetes Res Care; 2020 Sep; 8(1):. PubMed ID: 32933950
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of basal-bolus insulin at 1:1.5 ratio compared to 1:1 ratio using a weight-based initiation and titration (WIT2) algorithm in hospitalized patients with type 2 Diabetes: a multicenter, randomized, clinical study.
Zhang X; Yan D; Du T; Zhao Y; Zhang J; Zhang T; Lin M; Li Y; Li W
Diabetol Metab Syndr; 2023 Nov; 15(1):243. PubMed ID: 38008775
[TBL] [Abstract][Full Text] [Related]
3. Dosing of insulin glargine in the treatment of type 2 diabetes.
Barnett A
Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a basal insulin dose management smartphone application for controlling fasting blood glucose in patients with type-2 diabetes mellitus: A single-centre, randomised clinical study.
Luo E; Wan J; Su M; Wang J; Feng J; Xie X; Hong X
Clin Endocrinol (Oxf); 2023 Oct; 99(4):361-369. PubMed ID: 37528510
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of basal-bolus insulin regimens in the inpatient management of non-critically ill patients with type 2 diabetes: A systematic review and meta-analysis.
Christensen MB; Gotfredsen A; Nørgaard K
Diabetes Metab Res Rev; 2017 Jul; 33(5):. PubMed ID: 28067472
[TBL] [Abstract][Full Text] [Related]
6. Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting.
Aloi J; Bode BW; Ullal J; Chidester P; McFarland RS; Bedingfield AE; Mabrey M; Booth R; Mumpower A; Wallia A
J Diabetes Sci Technol; 2017 Jan; 11(1):12-16. PubMed ID: 27555601
[TBL] [Abstract][Full Text] [Related]
7. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine.
Davies M; Storms F; Shutler S; Bianchi-Biscay M; Gomis R;
Diabetes Care; 2005 Jun; 28(6):1282-8. PubMed ID: 15920040
[TBL] [Abstract][Full Text] [Related]
8. Decreased rates of hypoglycemia following implementation of a comprehensive computerized insulin order set and titration algorithm in the inpatient setting.
Sinha Gregory N; Seley JJ; Gerber LM; Tang C; Brillon D
Hosp Pract (1995); 2016 Dec; 44(5):260-265. PubMed ID: 27805455
[TBL] [Abstract][Full Text] [Related]
9. Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.
Roach P; Bai S; Charbonnel B; Consoli A; Taboga C; Tiengo A; Bolli G;
Clin Ther; 2004 Apr; 26(4):502-10. PubMed ID: 15189747
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of insulin degludec U100 and insulin glargine U100 in combination with meal-time bolus insulin in hospitalized patients with type 2 diabetes: an open-label, randomized controlled study.
Suzuki J; Yamakawa T; Oba M; Nagakura J; Shigematsu E; Tamura H; Takahashi K; Okamoto Y; Sakamoto R; Shinoda M; Takano T; Kadonosono K; Terauchi Y
Endocr J; 2019 Nov; 66(11):971-982. PubMed ID: 31270291
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Efficacy and Safety of Insulin Detemir and Insulin Glargine in Hospitalized Patients with Type 2 Diabetes: A Randomized Crossover Trial.
Zhang T; Lin M; Li W; Fan X; Du T; Zhao Y; Zhang X
Adv Ther; 2016 Feb; 33(2):178-85. PubMed ID: 26809253
[TBL] [Abstract][Full Text] [Related]
12. TITRATION: A Randomized Study to Assess 2 Treatment Algorithms with New Insulin Glargine 300 units/mL.
Yale JF; Berard L; Groleau M; Javadi P; Stewart J; Harris SB
Can J Diabetes; 2017 Oct; 41(5):478-484. PubMed ID: 28803820
[TBL] [Abstract][Full Text] [Related]
13. Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen.
Bergenstal RM; Peyrot M; Dreon DM; Aroda VR; Bailey TS; Brazg RL; Frias JP; Johnson ML; Klonoff DC; Kruger DF; Ramtoola S; Rosenstock J; Serusclat P; Weinstock RS; Naik RG; Shearer DM; Zraick V; Levy BL;
Diabetes Technol Ther; 2019 May; 21(5):273-285. PubMed ID: 31025878
[No Abstract] [Full Text] [Related]
14. A Propensity Score Matched Comparison of Brand and Biosimilar Basal Insulin in Non-Critical Hospitalized Patients with Type 2 Diabetes Mellitus.
Hu X; Zhang L; Dong C; Dong Y; Jiang J; Gao W
Adv Ther; 2019 May; 36(5):1132-1142. PubMed ID: 30900200
[TBL] [Abstract][Full Text] [Related]
15. Initiation of insulin glargine in suboptimally controlled patients with type 2 diabetes: sub-analysis of the AT.LANTUS trial comparing treatment outcomes in subjects from primary and secondary care in the UK.
Davies M; Evans R; Storms F; Gomis R; Khunti K
Diabetes Obes Metab; 2007 Sep; 9(5):706-13. PubMed ID: 17697063
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of insulin supplementation for correction of bedtime hyperglycemia in hospitalized patients with type 2 diabetes.
Vellanki P; Bean R; Oyedokun FA; Pasquel FJ; Smiley D; Farrokhi F; Newton C; Peng L; Umpierrez GE
Diabetes Care; 2015 Apr; 38(4):568-74. PubMed ID: 25665812
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Efficacy and Adherence of Patient-Preferred (1 Unit Daily) and ADA/EASD Guideline-Recommended (2 Units Every 3 Days) Basal Insulin Titration Algorithms: Multicenter, Randomized, Clinical Study.
Li L; Zhang X; Zhang T; Zeng L; Lin M; Li Y; Li W
Patient Prefer Adherence; 2024; 18():687-694. PubMed ID: 38524199
[TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease.
Ruiz de Adana MS; Colomo N; Maldonado-Araque C; Fontalba MI; Linares F; García-Torres F; Fernández R; Bautista C; Olveira G; de la Cruz JL; Rojo-Martínez G; Valdés S
Diabetes Res Clin Pract; 2015 Nov; 110(2):158-65. PubMed ID: 26474657
[TBL] [Abstract][Full Text] [Related]
19. Addressing hyperglycemia from hospital admission to discharge.
Moghissi ES
Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
[TBL] [Abstract][Full Text] [Related]
20. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
